Navigating Early-Stage M&A in Biotech: Challenges and Opportunities for Success

Are you part of an early-stage biotech company or a strategic acquirer looking for valuable insights into mergers and acquisitions? If so, mark your calendars for Monday, January 13, 2025, at 4 p.m. PT for a panel discussion at Harlan Records in San Francisco.

This event, hosted by Arnold & Porter, will address the challenges and opportunities associated with M&A in the biotech industry, particularly focusing on early-stage development companies. Experts will delve into the importance of intellectual property (IP) and technology transactions in driving growth, as well as explore alternative approaches to acquiring startups and navigating the unique dynamics of early-stage deals.

Additionally, the discussion will touch on human capital and People Ops considerations, highlighting strategies to identify and retain key talent within your organization. Following the panel, attendees will have the chance to network with industry leaders, innovators, and peers over cocktails.

Don’t miss this opportunity to gain valuable insights and expand your connections in the biotech M&A space. Register now and join us for an evening of learning and networking at Harlan Records. See you there!